Clear Search sequence regions


  • adult (1)
  • hormones (1)
  • humans (1)
  • hyperprolactinemia (4)
  • immunomodulators (1)
  • patients (3)
  • platelet (2)
  • prolactin (3)
  • serotonin (1)
  • strokes (9)
  • thrombin (1)
  • TXA2 (1)
  • Sizes of these terms reflect their relevance to your search.

    Strokes are the fifth leading cause of death in the United States with almost 800,000 patients seeking emergency care each year-most of whom are seen for ischemic strokes. Acute ischemic strokes (AIS) can be caused by emboli in diseases such as atrial fibrillation as well as thrombus formation in the form of platelet deposition in patients with atherosclerotic disease. Platelet activation by immunomodulators including thromboxane A2 (TXA2), serotonin, and thrombin have been extensively delineated; however, the activation by hormones such as prolactin has only recently been revealed. We present a case of a 25-year-old male with a history of pituitary microadenoma and hyperprolactinemia who presented with an acute ischemic stroke in the setting of medication non-compliance. To our knowledge, this is the first known case of AIS in a patient with known hyperprolactinemia who presented with a stroke due to be medication non-compliance. Published by Elsevier Inc.

    Citation

    Zane Elfessi, Danielle Dressler, Sara Johnson, Katerina Antonishina, Melody Suh. Hyperprolactinemia-induced acute ischemic stroke. The American journal of emergency medicine. 2023 Sep;71:249.e1-249.e2

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37468431

    View Full Text